TVRD
Tvardi Therapeutics
TVRD
TVRD
178 hedge funds and large institutions have $318M invested in Tvardi Therapeutics in 2022 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 50 increasing their positions, 59 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
15% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 59
18% less capital invested
Capital invested by funds: $387M → $318M (-$69.7M)
Holders
178
Holding in Top 10
–
Calls
$3.74M
Puts
$847K
Top Buyers
| 1 | +$24.2M | |
| 2 | +$7.11M | |
| 3 | +$2.51M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.5M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$2.44M |
Top Sellers
| 1 | -$11.2M | |
| 2 | -$5.58M | |
| 3 | -$1.93M | |
| 4 |
Renaissance Technologies
New York
|
-$1.93M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$1.52M |